| Ημερομηνία | barcode | code | περιεχομενο | τιμή παραγωγός | χονδρική | λιανική |
|---|---|---|---|---|---|---|
| 05/2018 | 2802473003018 | 247300301 | OVITRELLE IN.SO.PF.P 250mcg/0,5ML PF.PEN BTx1PF.PENx0,5ML+1 βελόνα βελόνα | 22.82 | 23.93 | 32.98 |
For the treatment of female infertility
Choriogonadotropin alfa binds to the Follicle stimulating hormone receptor which results in ovulation in the absence of sufficient endogenous Luteinizing hormone.
The mean absolute bioavailability following a single subcutaneous injection to healthy female volunteers is about 40%.
The mean terminal half-life is about 29 ± 6 hours (initial half-life is 4.5 ± 0.5 hours).
One-tenth of the dose is excreted in the urine.
* 5.9 ± 1.0 L
* 0.29 +/- 0.04 L/h [healthy down-regulated females]